MGF
Mechano Growth Factor · IGF-1Ec · IGF-IEc · PEG-MGF
Last updated
At a glance
Overview
Why MGF Sits in the Peptide Stack#
Mechano Growth Factor (MGF) is the local splice variant of IGF-1 your muscles release in the minutes after a heavy working set. It's the signal that wakes up quiescent satellite cells, tells them to proliferate, and delays their differentiation long enough to expand the myonuclear pool before IGF-1Ea takes over to drive actual fusion and protein synthesis. Injected as a synthetic E-peptide — or its pegylated long-acting form, PEG-MGF — it's used by physique-focused peptide users to amplify that satellite-cell pulse around training and to support muscle-belly recovery from hard blocks, AAS cycles, or outright injury.
The community uses it two ways: native MGF site-injected IM into the worked muscle immediately post-workout, exploiting its very short (~5–7 min) half-life to mimic endogenous physiology; or PEG-MGF dosed SubQ 2–3x/week for a sustained, hands-off version of the same signal. It's non-hormonal, doesn't aromatize, doesn't suppress the HPTA, and — importantly — doesn't crash blood sugar the way IGF-1 LR3 can, because the E-peptide doesn't meaningfully bind the IGF-1 receptor.
"MGF (IGF-IEc) appears to function by promoting satellite cell activation and muscle regeneration, with effects distinct from the systemic actions of IGF-I." — Dai et al., Growth Horm IGF Res (2010)
Set expectations honestly: MGF is a supporting compound, not a headline mass-builder. Users who run it solo and expect LR3-style results usually walk away unimpressed. Users who layer it into a dialed GH + IGF-1 + AAS protocol — or use it to rebuild a lagging bodypart or a torn muscle — tend to keep it in the toolkit. Below we cover native vs. PEG-MGF dosing, the post-workout site-injection protocol, half-life and timing, stacking with GH/IGF-1/BPC-157, tendon and muscle-repair use, cycle length, and the side effects and sourcing pitfalls worth knowing before you pin.
How MGF works
MGF is the IGF-1Ec splice variant — the local, muscle-specific isoform of IGF-1 that gets pulsed out by damaged fibers in the minutes after mechanical overload. The synthetic peptide sold as "MGF" (and its pegylated cousin PEG-MGF) is just the unique C-terminal E-domain of that splice variant, and its entire job is to activate satellite cells so you have more myonuclei available for hypertrophy and repair.
Alternative Splicing of the IGF-1 Gene#
The IGF-1 gene doesn't produce a single product. Under mechanical load, a 49-bp insert in exon 5 causes a reading-frame shift, yielding IGF-1Ec (the "MGF" splice variant) with a unique E-peptide C-terminus distinct from systemic IGF-1Ea. This happens before IGF-1Ea expression ramps up — MGF is the early-phase local signal, IGF-1Ea is the later protein-synthesis signal.
"A novel IGF-I splice variant, mechano growth factor (MGF), is rapidly upregulated in response to mechanical overload, preceding the expression of IGF-I itself." — Goldspink, G. J Anat, 1999
Practically: MGF is what the muscle releases when a heavy set damages fibers. The injected peptide is an attempt to replicate that pulse on demand, which is why post-workout site-injection into the trained muscle is the protocol that actually matches the biology.
Satellite Cell Activation and Delayed Differentiation#
This is the mechanism that matters for physique users. MGF activates quiescent Pax7⁺ satellite cells sitting on the basal lamina of muscle fibers, drives them to proliferate as myoblasts, and — critically — delays their terminal differentiation. That delay expands the myoblast pool before they fuse into existing fibers as new myonuclei.
"The muscle IGF-I gene produces multiple splice variants, and early in the response to mechanical stimuli, MGF is expressed, stimulating satellite cell activation and proliferation." — Goldspink, G. Int J Biochem Cell Biol, 2006
More myonuclei = higher ceiling for hypertrophy, because each nucleus only supports a limited volume of sarcoplasm (the "myonuclear domain" concept). This is why MGF pairs so well with GH and IGF-1 LR3: those drive the protein synthesis, MGF makes sure there are nuclei available to support the new tissue.
A Distinct Receptor Pathway (Not the IGF-1 Receptor)#
Here's the subtle point most guides get wrong: the injected E-peptide is not full IGF-1. It lacks the mature IGF-1 region, so it does not bind the IGF-1 receptor the way IGF-1 LR3 does. It appears to act through a still-poorly-characterized distinct receptor in muscle and neural tissue.
"MGF (IGF-IEc) appears to function by promoting satellite cell activation and muscle regeneration, with effects distinct from the systemic actions of IGF-I." — Dai Z, Wu F, Yeung EW, Li Y. Growth Horm IGF Res, 2010
The practical consequence: MGF does not meaningfully crash blood glucose the way LR3 does, does not hit the hypoglycemia ceiling that limits LR3 dosing, and does not feed back on the GH/IGF axis. That's a real advantage if you're stacking — you can run MGF alongside LR3 without compounding the glucose risk.
Pegylation and Systemic vs. Local Biology#
Native MGF has a half-life of ~5–7 minutes in the muscle interstitium — endogenous MGF is designed as a localized pulse, not a circulating hormone. PEG-MGF attaches a polyethylene-glycol chain that shields the peptide from proteases and renal filtration, stretching functional half-life into the 48–72 hour range (community-reported; no peer-reviewed human PK data).
| Form | Half-life | Timing strategy | Best use |
|---|---|---|---|
| Native MGF | ~5–7 min | IM site-injected within 30 min post-workout | Lagging-bodypart site work, mimicking endogenous pulse |
| PEG-MGF | ~48–72 hr | SubQ 2–3x/week, often night before training | Systemic satellite-cell priming alongside GH/IGF-1 stack |
The trade-off is real: native MGF matches the natural biology (local, short, post-damage) but is fragile, requires cold-chain discipline, and demands post-workout IM injection into the worked muscle. PEG-MGF sacrifices the localized-pulse fidelity for practicality and works more like a 2x/week systemic maintenance peptide.
Age-Related Decline and the Repair Ceiling#
MGF expression drops significantly with age, and this decline tracks the decline in regenerative capacity seen in aging muscle.
"The decline of MGF expression with age may contribute to reduced capacity for muscle repair and hypertrophy, emphasizing the importance of the local isoform in tissue regeneration." — Goldspink, G. Rejuvenation Research, 2007
This is part of why MGF gets pulled into injury-repair blocks (stacked with BPC-157 and TB-500) and recovery/bridge phases between AAS cycles — the satellite-cell angle is most defensible when there's actual damage to repair or when you want to preserve regenerative capacity during a lower-signal phase. Ran solo on an otherwise untrained, uninjured, low-androgen baseline, MGF's effects are subtle. Layered into a protocol where the rest of the hypertrophy machinery is already running, it's a genuine multiplier on the satellite-cell side.
Protocol
| Level | Dose | Frequency | Notes |
|---|---|---|---|
| Low | 100–200 mcg | 3× weekly | Documented entry-level range |
| Mid | 200–400 mcg | 3× weekly | Most commonly studied range |
| High | 400–800 mcg | 3× weekly | Native MGF: inject IM into the worked muscle within 30 min post-workout, 3–5x/week on training days. PEG-MGF: 2–3x/week SubQ, typically on non-training days or the evening before a session to prime satellite cells. |
Cycle length & outcomes
Documented cycle
4–8 weeks
Plateau after
8 wks
Cycle Length & Protocol#
MGF is run in short, purposeful blocks — it's not a compound you cruise on year-round. The satellite-cell activation window is what you're paying for, and most users see diminishing returns past the 6–8 week mark. No loading phase, no taper, no HPTA suppression to recover from.
MGF Protocol by Goal#
| Goal | Cycle Length | Dose & Frequency | Variant |
|---|---|---|---|
| Lagging bodypart / site work | 4 weeks | 200mcg IM post-workout, into worked muscle, 2–3x/week | Native MGF |
| General recovery / GH-axis stack | 6–8 weeks | 200–250mcg SubQ, 2–3x/week (non-training days or evening pre-workout) | PEG-MGF |
| Muscle injury / post-strain repair | 4–6 weeks | 200mcg SubQ 2x/week (often alongside BPC-157 + TB-500) | PEG-MGF |
| Advanced GH/IGF-1 stack | 6–8 weeks | 250–400mcg SubQ 2–3x/week | PEG-MGF |
| Bridge / cruise support | 4–6 weeks | 200mcg SubQ 2x/week | PEG-MGF |
Native vs PEG-MGF — Pick One#
The choice isn't really about potency, it's about logistics.
Native MGF is the biologically "correct" version — a short, local pulse into trained muscle, mimicking what the fiber does endogenously after mechanical overload. Half-life is only minutes, so timing matters:
"MGF is expressed early in the response to mechanical stimuli, stimulating satellite cell activation and proliferation." — Goldspink 2006, Int J Biochem Cell Biol
That means IM injection directly into the trained muscle within ~30 minutes of finishing the session. Outside that window you're wasting peptide. It also needs to be kept cold, used within days of reconstitution (or frozen in aliquots), and handled gently — no shaking.
PEG-MGF trades the tight local pulse for a plasma half-life in the range of 48–72 hours (community-reported — no formal human PK exists). It's dosed twice weekly and doesn't care whether you trained that day:
"PEG-MGF is typically dosed 200–250 mcg 2–3x per week, most often on non-training days or evenings before a workout, making it much more practical than native MGF." — r/amino_asylum PEG-MGF Guide
For almost everyone, PEG-MGF is the correct default. Native MGF is worth the hassle only if you're running a serious site-injection protocol on a specific muscle group.
Onset Timing & Expectations#
- Subjective recovery / pump quality: first 7–14 days
- Palpable tissue changes: 3–4 weeks of consistent dosing
- Real satellite-cell-driven myonuclear addition: requires the full 6–8 week block paired with heavy training — this is where results actually live
Set expectations honestly: MGF is a supporting compound, not a headline mass-builder. The users reporting strong results run it inside a dialed GH + IGF-1 + AAS protocol where satellite-cell expansion is the limiting factor.
"MGF (IGF-IEc) appears to function by promoting satellite cell activation and muscle regeneration, with effects distinct from the systemic actions of IGF-I." — Dai et al. 2010, Growth Horm IGF Res
Ran solo on a beginner training program, MGF is almost always described as "underwhelming" — because the mechanical stimulus isn't there for the expanded satellite-cell pool to service.
Loading, Tapering, and Time Off#
- No loading phase. Start at your target dose from day one.
- No taper required. Stop cleanly at the end of the block.
- Off-cycle: at least 4 weeks between blocks. There's no documented receptor downregulation, but long-term human data is nonexistent, and pulsing respects the biology — endogenous MGF itself is a pulse, not a baseline.
- PCT: not required. MGF is non-hormonal, non-suppressive, and does not aromatize.
Bloodwork Cadence#
Running MGF solo, there are no specific markers to track — it doesn't hit glucose, lipids, or the HPTA. When stacked inside a GH/IGF-1 protocol, monitor on the GH-axis schedule:
| Marker | Frequency |
|---|---|
| IGF-1 | Baseline + every 6–8 weeks on stack |
| Fasting glucose | Baseline + every 6–8 weeks |
| HbA1c | Baseline + every 3 months |
| Blood pressure | Weekly (home cuff) |
Skip MGF entirely if you have active malignancy or a recent cancer history — growth-factor peptides that expand stem-cell populations have no business in that context without oncology clearance.
Risks & mistakes
Common (most users)#
- Injection-site reactions — redness, mild swelling, or a transient lump at the injection site, especially with native MGF site-injected post-workout. Rotate within the worked muscle, use fresh pins, and ensure proper reconstitution technique (swirl, don't shake). Warming the vial slightly before injection can reduce sting.
- "MGF flu" / lethargy — some users report a dull, flu-like feeling 6–24 h after dosing, particularly at higher PEG-MGF doses. Usually resolves within a week of continued use. If it persists, drop the dose by 50 mcg and reassess.
- Mild post-injection soreness in the trained muscle — more noticeable than normal DOMS when native MGF is site-injected. This is expected and self-limiting.
- Vivid dreams / lighter sleep — anecdotally reported with evening PEG-MGF dosing. Shift the injection to morning if it bothers you.
Uncommon (dose-dependent or individual)#
- Persistent injection-site lumps or sterile abscess-like reactions — more common with poorly reconstituted native MGF (it's fragile and degrades fast). If lumps don't resolve within a few days, suspect product quality or technique before continuing.
- Headache or facial flushing — occasional at the upper end of the PEG-MGF dose range (300+ mcg per injection). Split the dose across two smaller injections per week.
- Mild water retention — uncommon and dose-dependent when stacked with GH or IGF-1 LR3. Attribute correctly before blaming MGF; drop GH first if it appears.
- Hypoglycemia — not a meaningful issue with the E-peptide, unlike IGF-1 LR3. The synthetic MGF fragment does not bind the IGF-1 receptor in the same way. If low-blood-sugar symptoms occur, the culprit is almost certainly another peptide in the stack (LR3, insulin, GH) — check the rest of the stack before attributing symptoms to MGF.
Rare but serious#
- Theoretical proliferative risk — MGF activates satellite cells and, more broadly, stem-cell-like populations. In the presence of undiagnosed malignancy this is a real (if unquantified) concern, as it is with any growth-factor peptide. Any unexplained lump, lymph node swelling, or persistent systemic symptom (night sweats, unintended weight loss) is a hard stop-and-investigate signal.
- Severe allergic reaction to the peptide or PEG moiety — rare, but PEG hypersensitivity is documented across pegylated biologics. Hives, difficulty breathing, or angioedema after injection = stop immediately and seek care.
- Counterfeit / contaminated product harm — the biggest real-world risk isn't the peptide, it's what's in the vial. Under-dosed, misfolded, or bacterially contaminated product is common in gray-market MGF. Source from vendors with third-party HPLC/MS COAs.
"MGF (IGF-IEc) appears to function by promoting satellite cell activation and muscle regeneration, with effects distinct from the systemic actions of IGF-I." — Dai Z et al., Growth Horm IGF Res (2010)
Hard contraindications#
- Active malignancy or recent cancer history — do not run MGF (or any growth-factor peptide) without oncology clearance. The satellite-cell activation mechanism is precisely the wrong signal to amplify in this context.
- Pregnancy and lactation — no safety data. Do not use.
- Known peptide or PEG hypersensitivity — if you've reacted to another pegylated biologic, do not run PEG-MGF.
- Undiagnosed lumps, masses, or suspicious lymphadenopathy — get these worked up before starting, not during.
Gender and PCT considerations#
MGF is non-hormonal — it does not aromatize, does not bind androgen receptors, and does not suppress the HPTA. No PCT is required when running MGF alone or alongside other peptides. Men and women use the same dose ranges; there are no virilization concerns and no menstrual-cycle effects reported. Women running MGF inside a peptide-only recomp protocol (e.g. with BPC-157 and low-dose GH) use it exactly as men do. When MGF is layered onto an AAS cycle, PCT is driven by the AAS — MGF itself contributes nothing to suppression and can be continued through PCT if desired.
Stack & combine
Multipliers applied when these compounds run together. Values > 1 indicate a bonus on that axis. Tap a partner to expand the mechanism.
| Partner | Type | Lean | Fat loss | Recovery |
|---|---|---|---|---|
| synergistic | ×1.18 | ×1.00 | ×1.25 |
FAQ — MGF
Where to buy
Swiss Chems
Affiliate link — we may earn a commission at no cost to you.
- Buy MGF without PEG 2 mg - SwissChems - Buy Best Quality Peptides, SARMS OnlineBuy MGF
Research & citations
5 studies cited on this page.
Conclusion
MGF (and PEG-MGF) carves out a clear niche for anyone looking to push muscle and tendon recovery, especially when paired with GH or IGF-1. It shines as a support compound for regeneration and satellite cell priming — not a standalone mass builder.
Key takeaways:
- Standard PEG-MGF dose: 200–250 µg SubQ, 2–3x/week, typically on non-training days or evenings before training
- Native MGF: 200–400 µg IM, site-injected into the worked muscle within 30 minutes post-workout
- Most run cycles for 4–8 weeks, followed by a recovery phase
- Stacks best alongside GH (2–4 IU/day) and/or IGF-1 LR3 to amplify satellite cell effect
- Minimal side effects, with injection site irritation most reported (no HPTA suppression, no PCT required)
- Purpose: prime satellite-cell pool and speed recovery from muscle damage, intense training, or soft-tissue injuries
If your main goal is actual muscle tissue regeneration and faster repair, especially post-injury or in the context of a heavy GH/IGF stack, MGF is one of the few peptides that delivers meaningfully in that lane.